Publication | Open Access

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial

Diabetes ManagementDiabetesDiabetes MellitusAntithymocyte Globulin TreatmentMedicineRecent-onset Type 112-Month Results